Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
46,631,948
-
Total 13F shares
-
22,613,677
-
Share change
-
-1,043,728
-
Total reported value
-
$38,441,999
-
Price per share
-
$1.70
-
Number of holders
-
51
-
Value change
-
-$6,722,259
-
Number of buys
-
28
-
Number of sells
-
21
Institutional Holders of Vigil Neuroscience, Inc. - Common Stock (VIGL) as of Q4 2024
As of 31 Dec 2024,
Vigil Neuroscience, Inc. - Common Stock (VIGL) was held by
51 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,613,677 shares.
The largest 10 holders included
Atlas Venture Life Science Advisors, LLC, Siren, L.L.C., BVF INC/IL, CITADEL ADVISORS LLC, SPHERA FUNDS MANAGEMENT LTD., 683 Capital Management, LLC, VANGUARD GROUP INC, Ensign Peak Advisors, Inc, Pivotal bioVenture Partners Investment Advisor LLC, and abrdn plc.
This page lists
51
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.